Through the "gatekeeper door": exploiting the active kinase conformation.

Article Details

Citation

Zuccotto F, Ardini E, Casale E, Angiolini M

Through the "gatekeeper door": exploiting the active kinase conformation.

J Med Chem. 2010 Apr 8;53(7):2681-94. doi: 10.1021/jm901443h.

PubMed ID
20000735 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamideVascular endothelial growth factor receptor 2IC 50 (nM)0.6N/AN/ADetails
Purvalanol AProto-oncogene tyrosine-protein kinase SrcIC 50 (nM)240N/AN/ADetails